Microbot+stemcell=cess micro robot mangia soldi agli umani(nasdaq:mbot)

  • Ecco la 70° Edizione del settimanale "Le opportunità di Borsa" dedicato ai consulenti finanziari ed esperti di borsa.

    Settimana di risk-off per i principali indici per via dei timori legati all’inflazione persistente e alle prospettive di tassi ancora elevati a lungo. Anche se il report di oggi sull’indice core Pce, la misura molto gradita alla Fed per valutare l’inflazione, ha mostrato un parziale raffreddamento, o quantomeno una stabilità. L’indice ha riportato una crescita su base annua del 2,8%, in linea con le previsioni degli analisti e con la rilevazione del mese precedente. Questo dovrebbe lasciare più margine di manovra alla Fed per abbassare i tassi di interesse nel corso del 2024. Passando al Vecchio Continente, il report sull’inflazione dell’Eurozona ha mostrato un indice al 2,6%, oltre il 2,5% atteso e in accelerazione rispetto al 2,4% precedente.
    Per continuare a leggere visita il link

La presenza di mbot in mezzo a tutta questa fuffa biotech è imbarazzante

Qua c'è una azienda vera che creerà valore vero (e sontuoso) per gli azionisti negli anni

Compra e dimentica
 
La presenza di mbot in mezzo a tutta questa fuffa biotech è imbarazzante

Qua c'è una azienda vera che creerà valore vero (e sontuoso) per gli azionisti negli anni

Compra e dimentica

Certo che nessuno può sapere se ci sarà tanta "sontuosità"...
Con questi ribassi e sotto il dollaro non la vedo tanto bene..
Se proprio non se ne può fare a meno.. qualcosa la si può prendere ora ma non escludo prezzi "migliori".
 
capperi meno 18 e stenta a recuperare adesso che gli indici sono verdi....adc o cosa? vedo un minimo 0,75 ma non vedo scambi a quel prezzo confermate? scende anche con volumi:censored:
 
capperi meno 18 e stenta a recuperare adesso che gli indici sono verdi....adc o cosa? vedo un minimo 0,75 ma non vedo scambi a quel prezzo confermate? scende anche con volumi:censored:

Io ho provato a 0,8 e mi ha servito in open
 
ask 9.834,5200 100
:eek:
 
vabbè, si ha sempre il 50 di possibilità o va su o va giù... fosse uscita una news buona non saremmo qui a criticarla
mah mi son messo un po a sfruculiare questo l'avete letto:

From November 22, 2017 through January 25, 2018, the holder of the Series A Convertible Preferred Stock, par value $0.01 per share (the “Preferred
Stock”), of Microbot Medical Inc. (the “Registrant”), converted an aggregate of 2,436 shares of the Preferred Stock for an aggregate of 2,436,000 shares of the
Registrant’s common stock. Pursuant to the terms of conversion of the Preferred Stock, each such share is convertible, upon request and for no additional
consideration, into 1,000 shares of the common stock of the Registrant. The issuances of the 2,436,000 shares of common stock were exempt from registration
under Section 4(a)(2) under the Securities Act of 1933, as amended and the rules promulgated thereunder (the “Securities Act”) as transactions not involving
a public offering to a single existing stockholder who is an accredited investor, and/or 3(a)(9) under the Securities Act as the Preferred Stock was exchanged
for common stock by an existing security holder and no commission or other remuneration was paid.

On January 31, 2018, the Registrant issued a press release announcing that it will host regularly scheduled Townhall Meetings to allow shareholders
and interested investors to get updates and participate in a Q&A session with senior executives of the Company. The initial Townhall Meeting is scheduled
for Thursday, February 1, 2018 at 4:30pm ET.
A copy of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference. The information
in this report (including Exhibit 99.1) is being furnished pursuant to Item 7.01 and shall not be deemed to be “filed” for the purposes of Section 18 of the
Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that section. This report will not be deemed an admission as to the
materiality of any information herein (including Exhibit 99.1).
 
mah mi son messo un po a sfruculiare questo l'avete letto:

From November 22, 2017 through January 25, 2018, the holder of the Series A Convertible Preferred Stock, par value $0.01 per share (the “Preferred
Stock”), of Microbot Medical Inc. (the “Registrant”), converted an aggregate of 2,436 shares of the Preferred Stock for an aggregate of 2,436,000 shares of the
Registrant’s common stock. Pursuant to the terms of conversion of the Preferred Stock, each such share is convertible, upon request and for no additional
consideration, into 1,000 shares of the common stock of the Registrant. The issuances of the 2,436,000 shares of common stock were exempt from registration
under Section 4(a)(2) under the Securities Act of 1933, as amended and the rules promulgated thereunder (the “Securities Act”) as transactions not involving
a public offering to a single existing stockholder who is an accredited investor, and/or 3(a)(9) under the Securities Act as the Preferred Stock was exchanged
for common stock by an existing security holder and no commission or other remuneration was paid.

On January 31, 2018, the Registrant issued a press release announcing that it will host regularly scheduled Townhall Meetings to allow shareholders
and interested investors to get updates and participate in a Q&A session with senior executives of the Company. The initial Townhall Meeting is scheduled
for Thursday, February 1, 2018 at 4:30pm ET.
A copy of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference. The information
in this report (including Exhibit 99.1) is being furnished pursuant to Item 7.01 and shall not be deemed to be “filed” for the purposes of Section 18 of the
Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that section. This report will not be deemed an admission as to the
materiality of any information herein (including Exhibit 99.1).

In generale qual'è la tua opinione Avio ?
Grazie
 
Indietro